↓ Skip to main content

Can LDL cholesterol be too low? Possible risks of extremely low levels

Overview of attention for article published in Journal of Internal Medicine, May 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news
3 news outlets
blogs
1 blog
twitter
26 X users
facebook
1 Facebook page
video
2 YouTube creators

Citations

dimensions_citation
76 Dimensions

Readers on

mendeley
161 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Can LDL cholesterol be too low? Possible risks of extremely low levels
Published in
Journal of Internal Medicine, May 2017
DOI 10.1111/joim.12614
Pubmed ID
Authors

A. G. Olsson, B. Angelin, G. Assmann, C. J. Binder, I. Björkhem, A. Cedazo‐Minguez, J. Cohen, A. von Eckardstein, E. Farinaro, D. Müller‐Wieland, K. G. Parhofer, P. Parini, R. S. Rosenson, J. Starup‐Linde, M. J. Tikkanen, L. Yvan‐Charvet

Abstract

Following the continuous accumulation of evidence supporting the beneficial role of reducing low-density lipoprotein cholesterol (LDL-C) levels in the treatment and prevention of atherosclerotic cardiovascular disease and its complications, therapeutic possibilities now exist to lower LDL-C to very low levels, similar to or even lower than those seen in newborns and nonhuman species. In addition to the important task of evaluating potential side-effects of such treatments, the question arises whether extremely low LDL-C levels per se may provoke adverse effects in humans. In this review, we summarize information from studies of human cellular and organ physiology, phenotypic characterization of rare genetic diseases of lipid metabolism, and experience from clinical trials. Specifically, we emphasize the importance of the robustness of the regulatory systems that maintain balanced fluxes and levels of cholesterol at both cellular and organismal levels. Even at extremely low LDL-C levels, critical capacities of steroid hormone and bile acid production are preserved, and the presence of a cholesterol blood-brain barrier protects cells in the central nervous system. Apparent relationships sometimes reported between less pronounced low LDL-C levels and disease states such as cancer, depression, infectious disease and others can generally be explained as secondary phenomena. Drug-related side-effects including an increased propensity for development of type 2 diabetes occur during statin treatment, while further evaluation of more potent LDL-lowering treatments such as PCSK9 inhibitors is needed. Experience from the ongoing large event-driven trials will be of great interest, and further evaluation including careful analysis of cognitive functions will be important. This article is protected by copyright. All rights reserved.

X Demographics

X Demographics

The data shown below were collected from the profiles of 26 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 161 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Finland 1 <1%
Netherlands 1 <1%
Unknown 159 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 23 14%
Student > Master 18 11%
Researcher 17 11%
Student > Ph. D. Student 17 11%
Student > Doctoral Student 14 9%
Other 31 19%
Unknown 41 25%
Readers by discipline Count As %
Medicine and Dentistry 54 34%
Pharmacology, Toxicology and Pharmaceutical Science 15 9%
Biochemistry, Genetics and Molecular Biology 12 7%
Agricultural and Biological Sciences 5 3%
Nursing and Health Professions 5 3%
Other 21 13%
Unknown 49 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 49. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 January 2024.
All research outputs
#862,905
of 25,464,544 outputs
Outputs from Journal of Internal Medicine
#188
of 3,003 outputs
Outputs of similar age
#17,515
of 327,179 outputs
Outputs of similar age from Journal of Internal Medicine
#6
of 27 outputs
Altmetric has tracked 25,464,544 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,003 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.2. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,179 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.